Skip to main content
APIC25 Annual Conference & Expo Main banner
Final Program


APIC25 Brochure
Back

Concurrent Education Session - 60 minutes

Public Health and Health Policy

Public Health Threats & Infectious Disease Prevention: Navigating Federal Actions and Their Impact

Tuesday, June 17, 2025
2:15 PM – 3:15 PM MST
Location: North Room 126
CE: 1

    Presenter(s)

  • Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA

    Consultant
    Infection Control International
    LEWISVILLE, North Carolina

    Disclosure(s): No financial relationships to disclose

  • DW

    David J. Weber, MD, MPH (he/him/his)

    Medical Director, Infection Prevention
    UNC Medical Center
    Chapel Hill, North Carolina

    Disclosure(s): BD USA: Consultant/Advisory Board (Ongoing); GAMA Healthcare: Consultant/Advisory Board (Ongoing); Germitec: Consultant/Advisory Board (Ongoing); GSK: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Merck & Co. Inc.: Speaker/Honoraria (Ongoing); Moderna: Adjudication Board (Ongoing); PDI, Inc: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

    • Moderator(s)

  • Maria Whitaker, BS, MT, CIC

    Infection Preventionist
    Infection, Prevention and Control Consulting Services

    Disclosure(s): No financial relationships to disclose

Session Description: Recent federal actions that limit communication, reduce funding, cut personnel, and eliminate critical public health programs and services pose significant challenges to the broader infectious disease and public health communities. The increasing spread of misinformation and regulatory uncertainty further complicates efforts to implement evidence-based practices, protect patients and communities, and sustain vital research and response programs.

In this joint session, APIC and SHEA will provide an overview of the evolving landscape, examining how federal actions impact infectious disease prevention, epidemiology, public health practice, and research. Presenters will explore the broader consequences of policy decisions on disease prevention efforts and outline APIC and SHEA’s response strategies

Learning Objectives:

  • Assess the impact of recent federal actions on infectious disease prevention.
  • Recognize how misinformation, regulatory shifts, and policy changes affect public health preparedness, research, and clinical practice
  • Explore the response efforts by APIC and SHEA to advocate for sustained public health programs, workforce protections, and evidence-based policies.